Xeomin® is the newest FDA cosmetic treatment to help treat the animation of brows or crows feet by selectively decreasing the muscle movement. Like Botox, Xeomin improves the appearance and decreases the prominence of existing frown lines, forehead furrows or crow’s feet.
In order to maintain results, treatment needs to be repeated about every 3-4 months. Xeomin is manufactured by Merz Pharmaceuticals and has been used by more than 84,000 people worldwide. It is now approved for use in 20 countries. The active ingredient in Xeomin is the same as Botox, but it does not contain any additives. For some, this may be a benefit, as your body may not develop antibodies to the product.
Looking younger and improving facial appearance often may be attained through non-surgical solutions such as using Xeomin. Decreasing animation and frown lines can make you look less tired and angry, creating a fresher and brighter look.
Who chooses Xeomin?
Age does not define candidates for facial rejuvenation. Women and men of various ages choose facial rejuvenation to delay or improve visible indications of facial aging. Millions of patients safely undergo Xeomin every year in the United States alone.
If you can clearly define why you want the injection, you understand what Xeomin can and cannot accomplish. You accept the risks of Xeomin and your responsibilities as a patient. If you have realistic expectations.
Results are not permanent and will need to be re-injected every 3 to 6 months to maintain results. Common side effects are light bruising and numbness, but are minimal and short in duration. You should understand that all cosmetic procedures carry the potential for risks, which will be fully discussed with you during your consultation.